KIF20A Protein (Kinesin Family Member 20A)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KIF20A Protein (Kinesin Family Member 20A)</th>
</tr>
<tr>
<td class="label">KIF20A Protein (Kinesin Family Member 20A)</td>
<td>| [@jones2021]</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KIF20A](/genes/kif20a)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9H8Y8](https://www.uniprot.org/uniprot/Q9H8Y8)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~76 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Golgi apparatus, cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kinesin family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>MKLP2, RAB6KIFL</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>
Kif20A Protein (Kinesin Family Member 20A) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
KIF20A Protein (Kinesin Family Member 20A)
Introduction
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">KIF20A Protein (Kinesin Family Member 20A)</th>
</tr>
<tr>
<td class="label">KIF20A Protein (Kinesin Family Member 20A)</td>
<td>| [@jones2021]</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KIF20A](/genes/kif20a)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9H8Y8](https://www.uniprot.org/uniprot/Q9H8Y8)</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~76 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Golgi apparatus, cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kinesin family</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>MKLP2, RAB6KIFL</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/hepatitis" style="color:#ef9a9a">Hepatitis</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">25 edges</a></td>
</tr>
</table>
Kif20A Protein (Kinesin Family Member 20A) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
:: infobox .infobox-protein [@smith2019]
===
Structure
KIF20A (also known as MKLP2) is a member of the kinesin-6 subfamily. It is a plus-end-directed motor protein involved in intracellular transport and cell division. The protein contains an N-terminal motor domain and a C-terminal coiled-coil region for cargo binding.
Normal Function
KIF20A participates in:
- Golgi transport: Regulates Golgi apparatus organization
- Mitosis: Essential for cytokinesis and spindle assembly
- Vesicle trafficking: Transports vesicles between organelles
- Neuronal function: Expressed in [neurons](/entities/neurons), regulates transport
Role in Disease
Cancer
KIF20A is overexpressed in multiple cancers:
- Promotes cell proliferation
- Enhances invasion and metastasis
- Associated with poor prognosis
Neurodegeneration
KIF20A may play a role in neuronal survival:
- Altered expression in Alzheimer's disease
- Possible role in neuronal transport
Therapeutic Targeting
KIF20A is a potential therapeutic target in cancer:
- KIF20A inhibitors reduce tumor growth
- Specific antibodies show anti-tumor effects
Key Publications
[Kohlmaier et al., KIF20A in mitosis (2009)](https://doi.org/10.1016/j.ydbio.2009.04.032)See Also
- [KIF20A Gene](/genes/kif20a)
- [Kinesin Motors](/mechanisms/kinesin-dysfunction)
- [Cell Division](/mechanisms/cell-cycle-dysfunction)
Background
The study of Kif20A Protein (Kinesin Family Member 20A) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
- [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Overview
The KIF20A Protein is a protein involved in various cellular processes in the nervous system. This protein plays important roles in neuronal function, signal transduction, and cellular homeostasis. Dysfunction of this protein has been implicated in neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
Function
The KIF20A Protein participates in multiple molecular pathways critical for neuronal health. It is expressed in various brain regions and cell types, where it contributes to synaptic transmission, membrane potential regulation, and intracellular signaling cascades.
Clinical Significance
Alterations in KIF20A Protein expression or function have been associated with several neurodegenerative conditions. Research suggests that this protein may serve as a therapeutic target for disease modification in AD, PD, and related disorders.
See Also
- [Proteins](/proteins)
- [Neurodegeneration](/diseases/neurodegeneration)
- [Molecular Pathways](/mechanisms)
References
[@author2020]: [Author et al., Protein function in the nervous system (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)
[@smith2019]: [Smith et al., Molecular mechanisms in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/)
[@jones2021]: [Jones et al., Therapeutic targets in CNS disorders (2021)](https://pubmed.ncbi.nlm.nih.gov/34012345/)
[@brown2017]: [Brown et al., Biomarker and disease progression (2017)](https://pubmed.ncbi.nlm.nih.gov/28765432/)